94 related articles for article (PubMed ID: 30048894)
1. Process-related impurities of eplerenone: determination and characterisation by HPLC methods and Raman spectroscopy.
Filip K; Łaszcz M; Leś A; Chmiel J
J Pharm Biomed Anal; 2018 Sep; 159():466-476. PubMed ID: 30048894
[TBL] [Abstract][Full Text] [Related]
2. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
Chandrashekara KA; Udupi A; Reddy CG
J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
[TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating ultra performance liquid chromatography method for the determination of potential process-related impurities in eplerenone.
Du M; Pan C; Chen J; Song M; Zhu T; Hang T
J Sep Sci; 2016 Aug; 39(15):2907-18. PubMed ID: 27256957
[TBL] [Abstract][Full Text] [Related]
4. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.
Karagiannidou EG; Bekiari ET; Vastardi EI
J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
6. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities.
Ferrarini A; Huidobro AL; Pellati F; Barbas C
J Pharm Biomed Anal; 2010 Oct; 53(2):122-9. PubMed ID: 20138727
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug.
Dams I; Białońska A; Cmoch P; Krupa M; Pietraszek A; Ostaszewska A; Chodyński M
Molecules; 2017 Aug; 22(8):. PubMed ID: 28809817
[TBL] [Abstract][Full Text] [Related]
9. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS.
Rao RN; Raju AN; Narsimha R; Babu GR
J Sep Sci; 2008 Jan; 31(1):107-18. PubMed ID: 18080239
[TBL] [Abstract][Full Text] [Related]
11. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
[TBL] [Abstract][Full Text] [Related]
12. Enantiomeric separation of S-zopiclone and its R-enantiomer in bulk drug samples by validated chiral RP-HPLC.
Sangaraju S; Lakshmi Kanth M; Rao BM; Someswararao N
Pharmazie; 2009 Nov; 64(11):717-9. PubMed ID: 20099514
[TBL] [Abstract][Full Text] [Related]
13. Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography method.
Zhou Y; Zhou W; Sun L; Zou Q; Wei P; OuYang P
J Sep Sci; 2014 Jun; 37(11):1248-55. PubMed ID: 24616424
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
15. RP-HPLC separation and characterization of unknown impurities of a novel HIV-protease inhibitor Darunavir by ESI-MS and 2D NMR spectroscopy.
Nageswara Rao R; Ramachandra B; Santhakumar K
J Pharm Biomed Anal; 2013 Mar; 75():186-91. PubMed ID: 23266664
[TBL] [Abstract][Full Text] [Related]
16. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
Gadapayale K; Kakde R; Sarma VU
J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
[TBL] [Abstract][Full Text] [Related]
17. Development of a Validated LC Method for Separation of Process-Related Impurities Including the R-Enantiomer of S-Pramipexole on Polysaccharide Chiral Stationary Phases.
Ramisetti NR; Kuntamukkala R; Arnipalli MS
Chirality; 2015 Jul; 27(7):430-5. PubMed ID: 25966024
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
Rao RN; Raju AN; Narsimha R
J Sep Sci; 2008 Jun; 31(10):1729-38. PubMed ID: 18481321
[TBL] [Abstract][Full Text] [Related]
19. HPLC-DAD and LC-ESI-MS analysis of doxycycline and related impurities in doxipan mix, a medicated premix for incorporation in medicated feedstuff.
Fiori J; Grassigli G; Filippi P; Gotti R; Cavrini V
J Pharm Biomed Anal; 2005 Apr; 37(5):979-85. PubMed ID: 15862676
[TBL] [Abstract][Full Text] [Related]
20. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
